MOGN

Japan's Eisai to post 22 percent fall in Q1 pretax profit - report - 07/16 - 06:29 PM ET

EISAI'S U.S. BIOPHARMA ACQUISITION ON TRACK FOR 1ST OP PROFIT - 06/10 - 02:37 AM ET

Japan's Eisai posts first-ever net loss on acquisition costs - 05/14 - 01:03 AM ET

FDA Advisory Committee Votes in Favor of Approval of Fospropofol Disodium Injection for Sedation - 05/07 - 05:33 PM ET

Japan's Eisai posts first-ever net loss after acquisition - report - 04/20 - 07:40 PM ET

Eisai issuer rating cut to 'A2' on higher leverage post MGI Pharma buy - Moody's - 03/05 - 03:22 AM ET

FDA Approves Aloxi(R) (Palonosetron HCl) Injection for Prevention of Postoperative Nausea and Vomiting - 03/03 - 02:37 PM ET

FDA approves Aloxi injection for nausea and vomiting - 03/03 - 05:05 AM ET

Eisai and partners win FDA approval for Aloxi injection for prevention of nausea - 03/03 - 02:20 AM ET

Eisai and partners win FDA approval for Aloxi injection for prevention of nausea - 03/03 - 02:20 AM ET

FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting - 03/02 - 09:00 PM ET

MOGN hits 52-week high at 41.05 - 01/28 - 10:13 AM ET

Eisai Reports Completion Of Tender Offer For MGI Pharma Shares - 01/26 - 08:04 AM ET

MGI Pharma (MOGN) Corporate Event Announcement Notice - 01/25 - 09:13 PM ET

EISAI WRAPS UP TENDER OFFER FOR U.S. FIRM MGI PHARMA - 01/23 - 10:15 PM ET

Eisai Says 96.1% MGI Pharma Shares Tendered - 01/23 - 12:17 PM ET

Eisai Announces Satisfaction Of Conditions To Tender Offer For MGI PHARMA Shares - 01/23 - 08:08 AM ET

MGI announces positive results from Gliadel combination study - 01/21 - 07:31 AM ET

MGI Pharma Reports Positive Results Of Gliadel Wafer And Radioactive Seeds To Treat Recurrent Glioblastoma Multiforme - 01/18 - 12:00 PM ET

MGI Pharma's Gliadel wafer/radioactive seeds show positive results in study - 01/18 - 10:39 AM ET

Page 1 of 8     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index